Acmp iv llc - see footnote investment history in Carbylan therapeutics inc

Filed on 2015-04-14 by Acmp Iv Llc SEC CIK 1282889 Form 4

Accession 0001209191-15-034053.txt Sec File: edgar/data/1282889/0001209191-15-034053-index.htm

2015-04-14 Acmp Iv Llc (CIK 1282889) through See Footnote

Invested in Carbylan Therapeutics Inc sold 332990 shares remaining shares owned 0

Convertible Promissory Note Carbylan Therapeutics Inc Cbyl underlying security shares 332990 underlying security title Common Stock

f4 the convertible promissory note is convertible into the number of shares of the issuer's common stock equal to the quotient obtained by dividing the entire principal amount and 41 days of accrued interest on the convertible promissory note by 80% of the initial public offering price of $5.00 per share of the issuer's common stock, automatically upon the closing of the issuer's initial public offering, and has no expiration date.
f2 these securities are held by acp iv, l.p ("acp iv"). daniel s. janney and guy p. nohra are directors of acmp iv, llc, the general partner of acp iv and disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.


Filed on 2015-04-14 by Acmp Iv Llc SEC CIK 1282889 Form 4

Accession 0001209191-15-034053.txt Sec File: edgar/data/1282889/0001209191-15-034053-index.htm

2015-04-14 Acmp Iv Llc (CIK 1282889) through See Footnote

Invested in Carbylan Therapeutics Inc sold 424346 shares remaining shares owned 0

Convertible Promissory Note Carbylan Therapeutics Inc Cbyl underlying security shares 424346 underlying security title Common Stock

f3 the convertible promissory note is convertible into the number of shares of the issuer's common stock equal to the quotient obtained by dividing the entire principal amount and 184 days of accrued interest on the convertible promissory note by 80% of the initial public offering price of $5.00 per share of the issuer's common stock, automatically upon the closing of the issuer's initial public offering, and has no expiration date.
f2 these securities are held by acp iv, l.p ("acp iv"). daniel s. janney and guy p. nohra are directors of acmp iv, llc, the general partner of acp iv and disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.


Filed on 2015-04-14 by Acmp Iv Llc SEC CIK 1282889 Form 4

Accession 0001209191-15-034053.txt Sec File: edgar/data/1282889/0001209191-15-034053-index.htm

2015-04-14 Acmp Iv Llc (CIK 1282889) through See Footnote

Invested in Carbylan Therapeutics Inc sold 1981124 shares remaining shares owned 0

Series B Convertible Preferred Stock Carbylan Therapeutics Inc Cbyl underlying security shares 1981124 underlying security title Common Stock

f1 upon the closing of the issuer's initial public offering, each share of series a convertible preferred stock and series b convertible preferred stock automatically converted into common stock on a one for one basis without payment or further consideration, and has no expiration date.
f2 these securities are held by acp iv, l.p ("acp iv"). daniel s. janney and guy p. nohra are directors of acmp iv, llc, the general partner of acp iv and disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.


Filed on 2015-04-14 by Acmp Iv Llc SEC CIK 1282889 Form 4

Accession 0001209191-15-034053.txt Sec File: edgar/data/1282889/0001209191-15-034053-index.htm

2015-04-14 Acmp Iv Llc (CIK 1282889) through See Footnote

Invested in Carbylan Therapeutics Inc sold 727590 shares remaining shares owned 0

Series A Convertible Preferred Stock Carbylan Therapeutics Inc Cbyl underlying security shares 727590 underlying security title Common Stock

f1 upon the closing of the issuer's initial public offering, each share of series a convertible preferred stock and series b convertible preferred stock automatically converted into common stock on a one for one basis without payment or further consideration, and has no expiration date.
f2 these securities are held by acp iv, l.p ("acp iv"). daniel s. janney and guy p. nohra are directors of acmp iv, llc, the general partner of acp iv and disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.


Filed on 2015-04-14 by Acmp Iv Llc SEC CIK 1282889 Form 4

Accession 0001209191-15-034053.txt Sec File: edgar/data/1282889/0001209191-15-034053-index.htm

2015-04-14 Acmp Iv Llc (CIK 1282889) through See Footnote

Invested in Carbylan Therapeutics Inc bought 877500 shares at $5.00 remaining shares owned 4343550

Common Stock Carbylan Therapeutics Inc Cbyl Transaction code: P Open market or private purchase of securities

f2 these securities are held by acp iv, l.p ("acp iv"). daniel s. janney and guy p. nohra are directors of acmp iv, llc, the general partner of acp iv and disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.


Filed on 2015-04-14 by Acmp Iv Llc SEC CIK 1282889 Form 4

Accession 0001209191-15-034053.txt Sec File: edgar/data/1282889/0001209191-15-034053-index.htm

2015-04-14 Acmp Iv Llc (CIK 1282889) through See Footnote

Invested in Carbylan Therapeutics Inc bought 332990 shares remaining shares owned 3466050

Common Stock Carbylan Therapeutics Inc Cbyl Transaction code: C Conversion of derivative security (usually options)

f4 the convertible promissory note is convertible into the number of shares of the issuer's common stock equal to the quotient obtained by dividing the entire principal amount and 41 days of accrued interest on the convertible promissory note by 80% of the initial public offering price of $5.00 per share of the issuer's common stock, automatically upon the closing of the issuer's initial public offering, and has no expiration date.
f2 these securities are held by acp iv, l.p ("acp iv"). daniel s. janney and guy p. nohra are directors of acmp iv, llc, the general partner of acp iv and disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.


Filed on 2015-04-14 by Acmp Iv Llc SEC CIK 1282889 Form 4

Accession 0001209191-15-034053.txt Sec File: edgar/data/1282889/0001209191-15-034053-index.htm

2015-04-14 Acmp Iv Llc (CIK 1282889) through See Footnote

Invested in Carbylan Therapeutics Inc bought 424346 shares remaining shares owned 3133060

Common Stock Carbylan Therapeutics Inc Cbyl Transaction code: C Conversion of derivative security (usually options)

f3 the convertible promissory note is convertible into the number of shares of the issuer's common stock equal to the quotient obtained by dividing the entire principal amount and 184 days of accrued interest on the convertible promissory note by 80% of the initial public offering price of $5.00 per share of the issuer's common stock, automatically upon the closing of the issuer's initial public offering, and has no expiration date.
f2 these securities are held by acp iv, l.p ("acp iv"). daniel s. janney and guy p. nohra are directors of acmp iv, llc, the general partner of acp iv and disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.


Filed on 2015-04-14 by Acmp Iv Llc SEC CIK 1282889 Form 4

Accession 0001209191-15-034053.txt Sec File: edgar/data/1282889/0001209191-15-034053-index.htm

2015-04-14 Acmp Iv Llc (CIK 1282889) through See Footnote

Invested in Carbylan Therapeutics Inc bought 1981124 shares remaining shares owned 2708714

Common Stock Carbylan Therapeutics Inc Cbyl Transaction code: C Conversion of derivative security (usually options)

f1 upon the closing of the issuer's initial public offering, each share of series a convertible preferred stock and series b convertible preferred stock automatically converted into common stock on a one for one basis without payment or further consideration, and has no expiration date.
f2 these securities are held by acp iv, l.p ("acp iv"). daniel s. janney and guy p. nohra are directors of acmp iv, llc, the general partner of acp iv and disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.


Filed on 2015-04-14 by Acmp Iv Llc SEC CIK 1282889 Form 4

Accession 0001209191-15-034053.txt Sec File: edgar/data/1282889/0001209191-15-034053-index.htm

2015-04-14 Acmp Iv Llc (CIK 1282889) through See Footnote

Invested in Carbylan Therapeutics Inc bought 727590 shares remaining shares owned 727590

Common Stock Carbylan Therapeutics Inc Cbyl Transaction code: C Conversion of derivative security (usually options)

f1 upon the closing of the issuer's initial public offering, each share of series a convertible preferred stock and series b convertible preferred stock automatically converted into common stock on a one for one basis without payment or further consideration, and has no expiration date.
f2 these securities are held by acp iv, l.p ("acp iv"). daniel s. janney and guy p. nohra are directors of acmp iv, llc, the general partner of acp iv and disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.